C型天然尿素类型:当前和未来的治疗应用
Despoina M Galetaki1, Andrew Dauber2,3
1Division of Endocrinology, Children's National Hospital, Washington, District of Columbia, USA, dgaletaki@childrensnational.org.
Hormone research in paediatrics
|February 8, 2024
概括
新型C型性尿素 (CNP) 类似物为身材矮小的儿童提供了新的治疗途径. 针对CNP/FGFR3通路显示出对遗传生长条件的前景.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 矮身是一个常见的儿科转诊,通常是遗传原因.
- 目前的治疗方法,如生长激素和IGF-1有局限性.
- 现有策略的重点是延长生长时间,而不是直接刺激.
研究的目的:
- 审查C型性尿素 (CNP) 的功能.
- 探索CNP类似物在治疗各种导致矮身的疾病中的潜力.
主要方法:
- 关于CNP路径及其在生长中的作用的文献综述.
- 对影响CNP信号的遗传变化的分析.
- 评估CNP类型的治疗潜力.
主要成果:
- CNP在骨生长中起着至关重要的作用.
- CNP/FGFR3通路的失调与遗传性矮身有关.
- CNP类似物代表了一种新的治疗方法.
结论:
- CNP通路是治疗遗传性矮身的一个关键目标.
- 在临床前和临床研究中,CNP类似物显示出有前途的结果.
- 针对CNP/FGFR3途径提供了一种促进增长的新战略.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
514
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
514
Antihypertensive Drugs: Vasodilators
524
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
524
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
165
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
165


